TCL Archive FDA Approval of Abraxane Sets Stage for Competition Between Taxane Drugs. Abraxane a Nanotechnology Drug? Sponsor Says Yes, FDA Says. January 14, 2005
TCL Archive Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded August 5, 2011
TCL Archive Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors June 24, 2011
TCL Archive How NCI Plans to Spend the $3 Billion Budget; But First, A Caveat From the Director November 19, 1999
